Experience with phase i of clinical pharmacology in the registration of drugs
Von Eickstedt, K.W.
Arzneimittel-Forschung 23(11 Suppl): 1677-1678
1973
ISSN/ISBN: 0004-4172 PMID: 4801617 Document Number: 65664
Document emailed within 1 workday
Related Documents
Yanaginuma, T. 1984: Clinical pharmacology for midwives. 3. Pregnancy and drugs. 3. Drugs with their risk superseding the benefits Josanpu Zasshi 38(6): 526-530Jaillon, P.; Dupuis, B. 1989: Prerequisites for phase i and phase Ii clinical trials of drugs Archives des Maladies du Coeur et des Vaisseaux 82(10): 1773-1776
Cepeláková, H.; Petrlík, M.; Cepelák, V.; Roubal, Z. 1979: Clinical pharmacology of phlebotropic drugs Folia Haematologica 106(5-6): 714-723
Stanulović, M. 1989: Clinical pharmacology and the selection of drugs Medicinski Pregled 42(11-12): 391-394
Greco, F.A.; Hande, K.R. 1979: The clinical pharmacology and use of antineoplastic drugs Journal of the Tennessee Medical Association 72(1): 23-33
Fanucchi, M.P.; Walsh, T.D.; Fleisher, M.; Lokos, G.; Williams, L.; Cassidy, C.; Vidal, P.; Chou, T.C.; Niedzwiecki, D.; Young, C.W. 1987: Phase i and clinical pharmacology study of trimetrexate administered weekly for three weeks Cancer Research 47(12): 3303-3308
Roden, D.M. 1985: Antiarrhythmic drugs. Clinical pharmacology of the old and the new agents Postgraduate Medicine 78(4): 28-37
Schilcher, R.B.; Haas, C.D.; Samson, M.K.; Young, J.D.; Baker, L.H. 1986: Phase i evaluation and clinical pharmacology of tricyclic nucleoside 5'-phosphate using a weekly intravenous regimen Cancer Research 46(6): 3147-3151
Singh, B.N.; Cho, Y.W.; Kuemmerle, H.P. 1981: Clinical pharmacology of antiarrhythmic drugs: a review and overview, part Ii International Journal of Clinical Pharmacology Therapy and Toxicology 19(5): 185-199
Sharma, P.L. 1976: Clinical pharmacology of adrenergic beta-receptor blocking drugs Journal of the Association of Physicians of India 24(11): 729-735
Farnier, M. 1992: The "duration of administration" factor in studies of clinical pharmacology of hypolipemic drugs Archives des Maladies du Coeur et des Vaisseaux 85(Special Issue 2): 113-115
Follath, F. 1991: Clinical pharmacology of antiarrhythmic drugs: variability of metabolism and dose requirements Journal of Cardiovascular Pharmacology 17(Suppl 6): S74-S76
Lozinskiĭ, L.G.; Venediktova, M.G.; Zakharova, G.I.; Sandomirskiĭ, B.L. 1986: Development of methods for research on the clinical pharmacology of drugs used in cardiovascular diseases Farmakologiia i Toksikologiia 49(5): 60-62
Larcan, A.; Toussain, P. 1985: Collaboration between the research center of a pharmaceutical firm and public emergency structures for better safety of phase i and Ii clinical pharmacology studies Therapie 40(4): 263-264
Vallano, A. 1996: Professional prospects in clinical pharmacology. An experience within the hospital Methods and Findings in Experimental and Clinical Pharmacology 18 Suppl C: 9-13
Witkowska, M. 1982: Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors Kardiologia Polska 25(2): 147-161
Loffreda, A.; Contaldi, C.; Santis, D.D.; Marabese, I.; Chiaiese, C.; Formato, P.; Motola, G.; Russo, F.; D'Alessio, O.; Lampa, E.; Rossi, F. 1997: Problems associated with the use and monitoring of cyclosporin. Experience at a Clinical Pharmacology Service Minerva Medica 88(12): 543-549
Vyas, B. 2001: European Association of Clinical Pharmacology and Therapeutics--Fifth Congress. Clinical pharmacology: from molecule to society--bridging the gap via Man IDrugs: the investigational drugs journal 4(10): 1133-1137
Rodríguez Moreno, C. 1996: Is clinical pharmacology important in primary health care? the Mallorca experience Atencion Primaria 17(1): 88; 90
Poulsen, H.Enghusen.; Schmitz, O.E.; Brøsen, K. 2002: Clinical pharmacology 2001--important events. The Danish Society of Clinical Pharmacology Ugeskrift for laeger 164(12): 1652